Full Text of HB4745 95th General Assembly
HB4745 95TH GENERAL ASSEMBLY
|
|
|
95TH GENERAL ASSEMBLY
State of Illinois
2007 and 2008 HB4745
Introduced , by Rep. Sara Feigenholtz SYNOPSIS AS INTRODUCED: |
|
720 ILCS 570/309 |
from Ch. 56 1/2, par. 1309 |
720 ILCS 570/312 |
from Ch. 56 1/2, par. 1312 |
|
Amends the Illinois Controlled Substances Act. Provides that a prescription for a Schedule II controlled substance must be filled by a mail-order pharmacy within 14 (rather than 7) days after issuance. Provides that an emergency prescription for a Schedule II controlled substance that is filled by a mail-order pharmacy must be verified by a written prescription within 14 (rather than 7) days.
|
| |
|
|
A BILL FOR
|
|
|
|
|
HB4745 |
|
LRB095 18419 RLC 44505 b |
|
| 1 |
| AN ACT concerning criminal law.
| 2 |
| Be it enacted by the People of the State of Illinois,
| 3 |
| represented in the General Assembly:
| 4 |
| Section 5. The Illinois Controlled Substances Act is | 5 |
| amended by changing Sections 309 and 312 as follows:
| 6 |
| (720 ILCS 570/309) (from Ch. 56 1/2, par. 1309)
| 7 |
| Sec. 309. On or after April 1, 2000, no person shall issue | 8 |
| a
prescription for a Schedule II
controlled substance, which is | 9 |
| a narcotic drug listed in Section 206 of
this Act; or which | 10 |
| contains any quantity of amphetamine or
methamphetamine, their | 11 |
| salts, optical isomers or salts of optical
isomers; | 12 |
| phenmetrazine and its salts; gluthethimide; and pentazocine, | 13 |
| other than on a written
prescription; provided
that in the case | 14 |
| of an emergency, epidemic or a
sudden or unforeseen accident or | 15 |
| calamity, the prescriber may issue a
lawful oral prescription | 16 |
| where failure to
issue such a prescription might result in
loss | 17 |
| of life or intense suffering, but such oral prescription shall
| 18 |
| include a statement by the prescriber concerning the accident
| 19 |
| or calamity, or circumstances constituting the emergency, the | 20 |
| cause for
which an oral prescription was used. Within
7 days , | 21 |
| or in case of a mail-order pharmacy within 14 days, after | 22 |
| issuing an
emergency prescription, the prescriber shall cause a | 23 |
| written prescription for
the emergency quantity prescribed to |
|
|
|
HB4745 |
- 2 - |
LRB095 18419 RLC 44505 b |
|
| 1 |
| be delivered to
the dispensing pharmacist. The prescription | 2 |
| shall have written on its face
"Authorization for Emergency | 3 |
| Dispensing", and the date of the emergency
prescription. The | 4 |
| written prescription
may be delivered to the pharmacist in | 5 |
| person, or by mail, but if delivered
by mail it must be | 6 |
| postmarked within the 7-day period , or in case of a mail-order | 7 |
| pharmacy within the 14-day period . Upon
receipt, the
dispensing | 8 |
| pharmacist shall attach this prescription to the emergency oral
| 9 |
| prescription earlier received and
reduced to writing. The | 10 |
| dispensing pharmacist shall notify the Department of
Human | 11 |
| Services if the prescriber
fails to deliver the authorization | 12 |
| for emergency dispensing on the
prescription to him. Failure of | 13 |
| the dispensing pharmacist to do so
shall void the authority | 14 |
| conferred by this paragraph to dispense without a
written | 15 |
| prescription of a
prescriber. All prescriptions issued for | 16 |
| Schedule II controlled substances
shall include both a written | 17 |
| and numerical notation of quantity on the face
of the | 18 |
| prescription. No prescription for a Schedule II controlled | 19 |
| substance
may
be refilled. The Department shall provide, at no | 20 |
| cost, audit reviews and necessary information to the Department | 21 |
| of Professional Regulation in conjunction with ongoing | 22 |
| investigations being conducted in whole or part by the | 23 |
| Department of Professional Regulation.
| 24 |
| (Source: P.A. 95-689, eff. 10-29-07.)
| 25 |
| (720 ILCS 570/312) (from Ch. 56 1/2, par. 1312)
|
|
|
|
HB4745 |
- 3 - |
LRB095 18419 RLC 44505 b |
|
| 1 |
| Sec. 312. Requirements for dispensing controlled | 2 |
| substances.
| 3 |
| (a) A practitioner, in good faith, may dispense a Schedule
| 4 |
| II controlled substance, which is a narcotic drug listed in | 5 |
| Section 206
of this Act; or which contains any quantity of | 6 |
| amphetamine or
methamphetamine, their salts, optical isomers | 7 |
| or salts of optical
isomers; phenmetrazine and its salts; or | 8 |
| pentazocine; and Schedule III, IV, or V controlled substances
| 9 |
| to any person upon
a written prescription of any prescriber, | 10 |
| dated and signed
by the
person prescribing on the day when | 11 |
| issued and bearing the name and
address of the patient for | 12 |
| whom, or the owner of the animal for which
the controlled | 13 |
| substance is dispensed, and the full name, address and
registry | 14 |
| number under the laws of the United States relating to
| 15 |
| controlled substances of the prescriber, if he is
required by
| 16 |
| those laws to be registered. If the prescription is for an | 17 |
| animal it
shall state the species of animal for which it is | 18 |
| ordered. The
practitioner filling the prescription shall write | 19 |
| the date of filling
and his own signature on the face of the | 20 |
| written prescription.
The written prescription shall be
| 21 |
| retained on file by the practitioner who filled it or pharmacy | 22 |
| in which
the prescription was filled for a period of 2 years, | 23 |
| so as to be readily
accessible for inspection or removal by any | 24 |
| officer or employee engaged
in the enforcement of this Act. | 25 |
| Whenever the practitioner's or
pharmacy's copy of any | 26 |
| prescription is removed by an officer or
employee engaged in |
|
|
|
HB4745 |
- 4 - |
LRB095 18419 RLC 44505 b |
|
| 1 |
| the enforcement of this Act, for the purpose of
investigation | 2 |
| or as evidence, such officer or employee shall give to the
| 3 |
| practitioner or pharmacy a receipt in lieu thereof. A | 4 |
| prescription
for a Schedule II controlled substance shall not | 5 |
| be filled more than 7 days , or in the case of a mail-order | 6 |
| pharmacy not more than 14 days,
after the date of issuance. A | 7 |
| written prescription for Schedule III, IV or
V controlled | 8 |
| substances shall not be filled or refilled more than 6 months
| 9 |
| after the date thereof or refilled more than 5 times unless | 10 |
| renewed, in
writing, by the prescriber.
| 11 |
| (b) In lieu of a written prescription required by this | 12 |
| Section, a
pharmacist, in good faith, may dispense Schedule | 13 |
| III, IV, or V
substances to any person either upon receiving a | 14 |
| facsimile of a written,
signed prescription transmitted by the | 15 |
| prescriber or the prescriber's agent
or upon a lawful oral | 16 |
| prescription of a
prescriber which oral prescription shall be | 17 |
| reduced
promptly to
writing by the pharmacist and such written | 18 |
| memorandum thereof shall be
dated on the day when such oral | 19 |
| prescription is received by the
pharmacist and shall bear the | 20 |
| full name and address of the ultimate user
for whom, or of the | 21 |
| owner of the animal for which the controlled
substance is | 22 |
| dispensed, and the full name, address, and registry number
| 23 |
| under the law of the United States relating to controlled | 24 |
| substances of
the prescriber prescribing if he is required by | 25 |
| those laws
to be so
registered, and the pharmacist filling such | 26 |
| oral prescription shall
write the date of filling and his own |
|
|
|
HB4745 |
- 5 - |
LRB095 18419 RLC 44505 b |
|
| 1 |
| signature on the face of such
written memorandum thereof. The | 2 |
| facsimile copy of the prescription or
written memorandum of the | 3 |
| oral
prescription shall be retained on file by the proprietor | 4 |
| of the pharmacy
in which it is filled for a period of not less | 5 |
| than two years, so as to
be readily accessible for inspection | 6 |
| by any officer or employee engaged
in the enforcement of this | 7 |
| Act in the same manner as a written
prescription. The facsimile | 8 |
| copy of the prescription or oral prescription
and the written | 9 |
| memorandum thereof
shall not be filled or refilled more than 6 | 10 |
| months after the date
thereof or be refilled more than 5 times, | 11 |
| unless renewed, in writing, by
the prescriber.
| 12 |
| (c) Except for any non-prescription targeted | 13 |
| methamphetamine precursor regulated by the Methamphetamine | 14 |
| Precursor Control Act, a
controlled substance included in | 15 |
| Schedule V shall not be
distributed or dispensed other than for | 16 |
| a medical purpose and not for
the purpose of evading this Act, | 17 |
| and then:
| 18 |
| (1) only personally by a person registered to dispense | 19 |
| a Schedule V
controlled substance and then only to his | 20 |
| patients, or
| 21 |
| (2) only personally by a pharmacist, and then only to a | 22 |
| person over
21 years of age who has identified himself to | 23 |
| the pharmacist by means of
2 positive documents of | 24 |
| identification.
| 25 |
| (3) the dispenser shall record the name and address of | 26 |
| the
purchaser, the name and quantity of the product, the |
|
|
|
HB4745 |
- 6 - |
LRB095 18419 RLC 44505 b |
|
| 1 |
| date and time of
the sale, and the dispenser's signature.
| 2 |
| (4) no person shall purchase or be dispensed more than | 3 |
| 120
milliliters or more than 120 grams of any Schedule V | 4 |
| substance which
contains codeine, dihydrocodeine, or any | 5 |
| salts thereof, or
ethylmorphine, or any salts thereof, in | 6 |
| any 96 hour period. The
purchaser shall sign a form, | 7 |
| approved by the Department of Professional
Regulation, | 8 |
| attesting that he has not purchased any Schedule V
| 9 |
| controlled substances within the immediately preceding 96 | 10 |
| hours.
| 11 |
| (5) a copy of the records of sale, including all | 12 |
| information
required by paragraph (3), shall be forwarded | 13 |
| to the Department of
Professional Regulation at its | 14 |
| principal office by the 15th day of the following month.
| 15 |
| (6) all records of purchases and sales shall be | 16 |
| maintained for not
less than 2 years.
| 17 |
| (7) no person shall obtain or attempt to obtain within | 18 |
| any
consecutive 96 hour period any Schedule V substances of | 19 |
| more than 120
milliliters or more than 120 grams containing | 20 |
| codeine, dihydrocodeine or
any of its salts, or | 21 |
| ethylmorphine or any of its salts. Any person
obtaining any | 22 |
| such preparations or combination of preparations in excess
| 23 |
| of this limitation shall be in unlawful possession of such | 24 |
| controlled
substance.
| 25 |
| (8) a person qualified to dispense controlled | 26 |
| substances under this
Act and registered thereunder shall |
|
|
|
HB4745 |
- 7 - |
LRB095 18419 RLC 44505 b |
|
| 1 |
| at no time maintain or keep in stock
a quantity of Schedule | 2 |
| V controlled substances defined and listed in
Section 212 | 3 |
| (b) (1), (2) or (3) in excess of 4.5 liters for each
| 4 |
| substance; a pharmacy shall at no time maintain or keep in | 5 |
| stock a
quantity of Schedule V controlled substances as | 6 |
| defined in excess of 4.5
liters for each substance, plus | 7 |
| the additional quantity of controlled
substances necessary | 8 |
| to fill the largest number of prescription orders
filled by | 9 |
| that pharmacy for such controlled substances in any one | 10 |
| week
in the previous year. These limitations shall not | 11 |
| apply to Schedule V
controlled substances which Federal law | 12 |
| prohibits from being dispensed
without a prescription.
| 13 |
| (9) no person shall distribute or dispense butyl | 14 |
| nitrite for
inhalation or other introduction into the human | 15 |
| body for euphoric or
physical effect.
| 16 |
| (d) Every practitioner shall keep a record of controlled | 17 |
| substances
received by him and a record of all such controlled | 18 |
| substances
administered, dispensed or professionally used by | 19 |
| him otherwise than by
prescription. It shall, however, be | 20 |
| sufficient compliance with this
paragraph if any practitioner | 21 |
| utilizing controlled substances listed in
Schedules III, IV and | 22 |
| V shall keep a record of all those substances
dispensed and | 23 |
| distributed by him other than those controlled substances
which | 24 |
| are administered by the direct application of a controlled
| 25 |
| substance, whether by injection, inhalation, ingestion, or any | 26 |
| other
means to the body of a patient or research subject. A |
|
|
|
HB4745 |
- 8 - |
LRB095 18419 RLC 44505 b |
|
| 1 |
| practitioner who
dispenses, other than by administering, a | 2 |
| controlled substance in
Schedule II, which is a narcotic drug | 3 |
| listed in Section 206 of this Act,
or which contains any | 4 |
| quantity of amphetamine or methamphetamine, their
salts, | 5 |
| optical isomers or salts of optical isomers, pentazocine, or
| 6 |
| methaqualone shall do so only upon
the issuance of a written | 7 |
| prescription blank by a
prescriber.
| 8 |
| (e) Whenever a manufacturer distributes a controlled | 9 |
| substance in a
package prepared by him, and whenever a | 10 |
| wholesale distributor
distributes a controlled substance in a | 11 |
| package prepared by him or the
manufacturer, he shall securely | 12 |
| affix to each package in which that
substance is contained a | 13 |
| label showing in legible English the name and
address of the | 14 |
| manufacturer, the distributor and the quantity, kind and
form | 15 |
| of controlled substance contained therein. No person except a
| 16 |
| pharmacist and only for the purposes of filling a prescription | 17 |
| under
this Act, shall alter, deface or remove any label so | 18 |
| affixed.
| 19 |
| (f) Whenever a practitioner dispenses any controlled | 20 |
| substance except a non-prescription targeted methamphetamine | 21 |
| precursor regulated by the Methamphetamine Precursor Control | 22 |
| Act, he
shall affix to the container in which such substance is | 23 |
| sold or
dispensed, a label indicating the date of initial | 24 |
| filling, the practitioner's
name and address, the name
of the | 25 |
| patient, the name of the prescriber,
the directions
for use and | 26 |
| cautionary statements, if any, contained in any prescription
or |
|
|
|
HB4745 |
- 9 - |
LRB095 18419 RLC 44505 b |
|
| 1 |
| required by law, the proprietary name or names or the | 2 |
| established name
of the controlled substance, and the dosage | 3 |
| and quantity, except as otherwise
authorized by regulation by | 4 |
| the Department of Professional Regulation. No
person shall | 5 |
| alter, deface or remove any label so affixed.
| 6 |
| (g) A person to whom or for whose use any controlled | 7 |
| substance has
been prescribed or dispensed by a practitioner, | 8 |
| or other persons
authorized under this Act, and the owner of | 9 |
| any animal for which such
substance has been prescribed or | 10 |
| dispensed by a veterinarian, may
lawfully possess such | 11 |
| substance only in the container in which it was
delivered to | 12 |
| him by the person dispensing such substance.
| 13 |
| (h) The responsibility for the proper prescribing or | 14 |
| dispensing of
controlled substances is upon the prescriber and | 15 |
| the responsibility for
the proper filling of a prescription for | 16 |
| controlled substance drugs
rests with the pharmacist. An order | 17 |
| purporting to be a prescription
issued to any individual, which | 18 |
| is not in the regular course of
professional treatment nor part | 19 |
| of an authorized methadone maintenance
program, nor in | 20 |
| legitimate and authorized research instituted by any
| 21 |
| accredited hospital, educational institution, charitable | 22 |
| foundation, or
federal, state or local governmental agency, and | 23 |
| which is intended to
provide that individual with controlled | 24 |
| substances sufficient to
maintain that individual's or any | 25 |
| other individual's physical or
psychological addiction, | 26 |
| habitual or customary use, dependence, or
diversion of that |
|
|
|
HB4745 |
- 10 - |
LRB095 18419 RLC 44505 b |
|
| 1 |
| controlled substance is not a prescription within the
meaning | 2 |
| and intent of this Act; and the person issuing it, shall be
| 3 |
| subject to the penalties provided for violations of the law | 4 |
| relating to
controlled substances.
| 5 |
| (i) A prescriber shall not preprint or cause to be
| 6 |
| preprinted a
prescription for any controlled substance; nor | 7 |
| shall any practitioner
issue, fill or cause to be issued or | 8 |
| filled, a preprinted prescription
for any controlled | 9 |
| substance.
| 10 |
| (j) No person shall manufacture, dispense, deliver, | 11 |
| possess with
intent to deliver, prescribe, or administer or | 12 |
| cause to be administered
under his direction any anabolic | 13 |
| steroid, for any use in humans other than
the treatment of | 14 |
| disease in accordance with the order of a physician licensed
to | 15 |
| practice medicine in all its branches for a
valid medical | 16 |
| purpose in the course of professional practice. The use of
| 17 |
| anabolic steroids for the purpose of hormonal manipulation that | 18 |
| is intended
to increase muscle mass, strength or weight without | 19 |
| a medical necessity to
do so, or for the intended purpose of | 20 |
| improving physical appearance or
performance in any form of | 21 |
| exercise, sport, or game, is not a valid medical
purpose or in | 22 |
| the course of professional practice.
| 23 |
| (Source: P.A. 94-694, eff. 1-15-06; 94-830, eff. 6-5-06.)
|
|